Shahin Hatamian, senior vice president of product management at Mitchell, believes the use of data and analytics have seen major innovation in the industry.
Discover how vocational case management can reduce claim costs and improve return-to-work outcomes. Essential guide for claims professionals seeking efficient claim resolution.
Enlyte’s Nikki Wilson weighs in on suzetrigine as a potential opioid alternative in workers’ comp. Discover what this breakthrough could mean for pain management and claims strategies.
Explore the immediate effects of President Trump's 2025 health care executive order on workers' compensation and auto insurers, including rising drug costs and supply chain disruptions.
Enlyte's new Drug Trends Report shows 7.8% drop in opioid use while migraine medications rise 8.7% in workers' comp claims during 2024.
Bird flu, or avian influenza, is an emerging public health and industry concern across North America. While the virus primarily affects birds, it can occasionally spread to humans—raising important questions around occupational exposure and public health safety.
Enlyte report shows migraine medications gaining popularity in workers' comp while opioid prescriptions continue downward trend in 2024.